Immediate Management of Hyperglycemic Crisis
A patient with diabetes presenting in hyperglycemic crisis requires immediate intravenous fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hr, followed by continuous IV insulin infusion at 0.1 units/kg/hr after initial fluid bolus, with aggressive potassium monitoring and replacement to prevent life-threatening complications. 1, 2
Initial Assessment and Diagnostic Confirmation
Rapidly assess for DKA versus HHS by checking blood glucose, arterial or venous pH, bicarbonate, and ketones (preferably β-hydroxybutyrate in blood rather than urine ketones). 1, 2
- DKA criteria: Blood glucose >250 mg/dL, arterial pH <7.3, bicarbonate <15 mEq/L, and moderate ketonemia or ketonuria 1
- HHS presentation: More gradual onset over days to a week with severe dehydration, altered mental status, and extreme hyperglycemia (often >600 mg/dL) but minimal ketosis 3, 4
- The combination of vomiting with ketosis strongly indicates DKA requiring immediate intervention 1, 3
Identify precipitating factors immediately: infection (most common), medication non-adherence, new-onset diabetes, myocardial infarction, or stroke. 1, 5
Step 1: Aggressive Fluid Resuscitation (FIRST PRIORITY)
Begin isotonic saline (0.9% NaCl) at 15-20 mL/kg/hr during the first hour to restore circulatory volume and tissue perfusion. 1, 2
- After the first hour, continue at 4-14 mL/kg/hr based on hemodynamic status 1
- Dehydration is a critical factor that increases hospitalization risk and mortality 6
- Critical pitfall: Do not delay fluid resuscitation while waiting for laboratory results 4
Step 2: Insulin Therapy (After Initial Fluid Bolus)
Start continuous IV regular insulin at 0.1 units/kg/hr after fluid resuscitation has begun. 1, 2, 7
- If glucose does not fall by 50-75 mg/dL in the first hour, double the insulin infusion rate 1
- Once blood glucose reaches 200-250 mg/dL, add dextrose to IV fluids while continuing insulin infusion to prevent hypoglycemia and allow continued clearance of ketones 1
- Critical pitfall: Never discontinue IV insulin prematurely—continue until ketones clear, not just until glucose normalizes 1, 4
Step 3: Potassium Management (ESSENTIAL)
Monitor serum potassium every 2-4 hours as insulin therapy drives potassium intracellularly, causing potentially fatal hypokalemia. 1, 7
- Begin potassium replacement when serum levels fall below 5.2 mEq/L, provided adequate urine output is present 1
- Typical replacement is 20-30 mEq per liter of IV fluid 1
- Critical warning: Untreated hypokalemia can cause respiratory paralysis, ventricular arrhythmia, and death 7
Ongoing Monitoring Requirements
Check blood glucose every 1-2 hours until stable and monitor electrolytes, BUN, creatinine, and venous pH every 2-4 hours. 1, 2
- Assess for cerebral edema (especially in children and adolescents): headache, altered mental status, seizures, bradycardia 1
- Monitor for signs of treatment complications including hypoglycemia and hypokalemia 7, 4
Transition to Subcutaneous Insulin
Administer subcutaneous basal insulin 2-4 hours BEFORE discontinuing IV insulin to prevent rebound hyperglycemia and recurrent ketoacidosis. 1, 2
- Critical pitfall: Premature termination of IV insulin or insufficient overlap with subcutaneous insulin is a common management error that leads to recurrence 4
- Target pre-meal glucose <140 mg/dL and random glucose <180 mg/dL for non-critically ill patients 2
Special Populations Requiring Modified Approach
Pregnant patients: Any concern for DKA requires immediate medical attention due to significant feto-maternal harm risk; may present with euglycemic DKA (glucose <200 mg/dL). 3
SGLT2 inhibitor users: Can develop euglycemic DKA with normal or near-normal glucose levels, requiring the same urgent management despite lower glucose readings. 1, 3
Children: Higher risk of cerebral edema during treatment, requiring closer monitoring during fluid resuscitation. 3
Critical Management Pitfalls to Avoid
- Never discontinue insulin during illness, even if the patient is not eating—this precipitates DKA 6, 3
- Do not stop IV insulin when glucose normalizes; continue until ketones clear 1, 4
- Do not forget potassium replacement—insulin therapy without potassium monitoring is dangerous 1, 7
- Ensure adequate overlap between IV and subcutaneous insulin (2-4 hours) 1, 2, 4
Treatment of Underlying Precipitating Factors
Identify and aggressively treat infection or other stressors that triggered the crisis. 6, 1
- Aggressive glycemic management with insulin may reduce morbidity in severe acute illness 6
- A physician with expertise in diabetes management should oversee hospitalized patient care 6
Prevention of Recurrence
Review sick-day management: Never discontinue insulin during illness, monitor blood glucose and ketones when glucose >200-300 mg/dL, seek professional advice early. 1, 3